Alexis C Bouteneff, MD | |
105 Buell Rd, Litchfield, CT 06759-3006 | |
(860) 567-9893 | |
Not Available |
Full Name | Alexis C Bouteneff |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 105 Buell Rd, Litchfield, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316982515 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 64523 (Minnesota) | Secondary |
207Y00000X | Otolaryngology | C158137 (California) | Secondary |
207Y00000X | Otolaryngology | 023370 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alexis C Bouteneff, MD 105 Buell Rd, Litchfield, CT 06759-3006 Ph: (860) 567-9893 | Alexis C Bouteneff, MD 105 Buell Rd, Litchfield, CT 06759-3006 Ph: (860) 567-9893 |
News Archive
Children's Hospital Los Angeles announces the availability of the EOS Imaging System, the first technology capable of providing head-to-toe images of patients in both 2D and 3D while using up to 90 percent less radiation than X-rays.
Three people were arrested this morning for allegedly orchestrating a scheme to defraud the customers of Employers Mutual LLC, a company that purported to provide health care coverage to more than 20,000 people across the United States, but left more than $30 million in unpaid claims for medical services when it was shut down.
A new study from University of Illinois at Chicago researchers suggests that more than one-third of U.S. adults may be using prescription medications that have the potential to cause depression or increase the risk of suicide, and that because these medications are common and often have nothing to do with depression, patients and health care providers may be unaware of the risk.
A balance between the activation of the inflammatory macrophages and suppression of the anti-inflammatory macrophages in the kidney may play a pivotal role in kidney stone formation. These macrophage-derived mediators may have potential as biomarkers to reflect the urinary stone risk, according to a new study from Japan, which was recently presented at the recent 2nd Meeting of the EAU Section of Urolithiasis and received Clinical Research Award.
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has acquired assets relating to the vaccine HibTITER from Wyeth LLC, a wholly owned subsidiary of Pfizer Inc, for the U.S. and many other markets, including Japan and Korea. Financial terms of the sale were not disclosed.
› Verified 7 days ago